Pharmacological [bmod]
Measures [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
High Risk [qlco]
Isolated [ftcn]
Cases [ftcn]
randomized [resa]
Study [mnob]
North [spco]
Indian [popg]
objectives [inpr]
High Density Lipoprotein Cholesterol [bacs, lipd]
Established [qlco]
coronary heart disease [dsyn]
Variety [cnce]
Lipid [lipd]
MODIFY [ftcn]
Drugs [phsu]
Best [qlco]
Single [popg]
Drug Therapy [topp]
High density lipoprotein cholesterol level [lbpr]
High Risk [qlco]
Isolated [ftcn]
Low Density Lipoprotein Cholesterol [bacs, strd]
Cases [ftcn]
Identified [qlco]
objectives [inpr]
Present [qnco]
Study [mnob]
Evaluate [ftcn]
Best [qlco]
Pharmacological [bmod]
Measure [qnco]
atorvastatin [orch, phsu]
Fenofibrate [orch, phsu]
Niacin [orch, phsu, vita]
High Density Lipoprotein Cholesterol [bacs, lipd]
Decreasing [qlco]
Estimated [qnco]
Framingham [inpr]
Coronary heart disease risk [inpr]
Percentage [qnco]
coronary heart disease [dsyn]
RP [gngm]
High Risk [qlco]
Isolated cases [fndg]
low hdl [fndg]
North [spco]
India [geoa]
Methods [inpr]
coronary heart disease [dsyn]
Equivalent [qlco]
coronary heart disease [dsyn]
RP [gngm]
Isolated cases [fndg]
low hdl [fndg]
Assigned [ftcn]
treatment [ftcn]
atorvastatin 10 MG [clnd]
N NOS [aapp, imft]
Fenofibrate 160 MG [clnd]
N NOS [aapp, imft]
Niacin 750 MG [clnd]
Extended Release [bodm]
N NOS [aapp, imft]
treatment [ftcn]
Dosages [qnco]
Drugs [phsu]
doubled [ftcn]
Patients [podg]
Assessed [acty]
Lipid [lipd]
Values [qlco]
baseline [bodm]
Characteristics [qlco]
Group [idcn]
Niacin 750 MG [clnd]
therapy [ftcn]
g/day [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
10^3 [qnco]
Percent [qnco]
P NOS [aapp, imft]
Fenofibrate [orch, phsu]
mg day [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Percent [qnco]
P NOS [aapp, imft]
atorvastatin [orch, phsu]
mg day [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Percent [qnco]
Percent [qnco]
Increasing [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Values [qlco]
Niacin [orch, phsu, vita]
effective [qlco]
reduction [npop]
coronary heart disease [dsyn]
RP [gngm]
P NOS [aapp, imft]
Fenofibrate [orch, phsu]
P NOS [aapp, imft]
0.010" [qnco]
atorvastatin [orch, phsu]
Interpretation [inpr]
Conclusions [idcn]
findings [ftcn]
Niacin [orch, phsu, vita]
Fibrates [orch, phsu]
Statins [orch, phsu]
effective [qlco]
therapy [ftcn]
Increasing [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Reducing [qlco]
Cumulative [qlco]
Coronary heart disease risk [inpr]
Isolated cases [fndg]
low hdl [fndg]
